AwardedSpainGoodsFramework agreement
Acuerdo Marco del Suministro del MEDICAMENTO RANIBIZUMAB
- Published
- Published 4 February 2026
- Deadline
- Closed 9 March 2026
Overview
A framework agreement for the supply of the pharmaceutical medicine Ranibizumab has been awarded to Novartis Farmaceutica S.A., Orion Pharma S.L., and Teva Pharma by the Consortium for Health and Social Care of Catalonia. The procurement is now complete as of June 8, 2026.
Key details
- Country
- Spain
- Status
- Awarded
- Category
- Goods
- Procedure
- Open
- Contract type
- Framework agreement
- Published
- 4 February 2026
- Deadline
- Closed
Various medicinal products
Award outcome
- Awarded value
- €0
- Award date
- 8 June 2026
- Contract period
- — → 8 June 2027
- NOVARTIS FARMACEUTICA, S.A.
- ORION PHARMA, S.L.
- TEVA PHARMA
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
9 June 2026
Contract Notice
4 February 2026
Contracting authority
Consorci de Salut i d'Atenció Social de Catalunya
Procuring entityNo consta, Spain
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.